The Claim
Annual whole-body MRI in adults with Li-Fraumeni syndrome is associated with the detection of early-stage (stage 1/2) cancers in 78% of cases detected by whole-body MRI, but has a modest sensitivity of 42.9% across all cancer types and fails to detect 47% of cancers that arise between scans.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For people with Li-Fraumeni syndrome, getting a full-body MRI every year can find early cancers in most cases where a cancer is spotted—but it still misses nearly half of all cancers, including many that show up between scans.
See the scientific wording
Annual whole-body MRI in adults with Li-Fraumeni syndrome is associated with detection of early-stage (stage 1/2) cancers in 78% of WB-MRI-detected cases, but has a modest sensitivity of 42.9% across all cancer types and fails to detect 47% of cancers that arise between scans.
What the research says
1 studyStudy: Evaluation of whole-body MRI for cancer early detection in Li-Fraumeni syndrome
This study found that yearly full-body MRI scans in people with Li-Fraumeni syndrome catch most early cancers (78% of detected ones), but still miss nearly half of all cancers that show up between scans — exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.